Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002007761 | SCV002260790 | uncertain significance | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 1233 of the COL4A1 protein (p.Gly1233Glu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL4A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1474956). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV003493901 | SCV004242427 | likely pathogenic | Brain small vessel disease 1 with or without ocular anomalies | 2022-08-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002007761 | SCV005440886 | likely pathogenic | not provided | 2024-06-25 | criteria provided, single submitter | clinical testing | Identified in a patient with pediatric epilepsy, chronic migraines, exertional weakness, sensory disturbance, and white matter signal abnormalities on brain MRI; the patient's daughter had autism, seizures, and similar brain findings (PMID: 38074064); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 38074064) |